[PR Newswire] – THOUSAND OAKS, Calif., April 28, 2016 /PRNewswire/ — Amgen ( NASDAQ:AMGN ) today announced financial results for the first quarter of 2016. Key results include: Total revenues increased 10 percent versus … Read more on this. Amgen Inc. (AMGN) , valued at $120.43B, opened at $159.60. During the trading session, AMGN traded between $159.36 to $163.68 with a one year range of $130.09 to $181.81. AMGN shares are currently priced at 14.88x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -1.94x forward p/e ratio. And for income investors, the company pays shareholders $4.00 per share annually in dividends, yielding 2.45%. Consensus earnings for the current quarter by the 20 sell-side analysts covering the stock is an estimate of $2.60 per share, which would be $0.12 better than the year-ago quarter and a $0.03 sequential increase. The full-year EPS estimate is $10.82, which would be a $0.44 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $5.32 Billion. If reported, that would be a 5.77% increase over the year-ago quarter. Recently, Citigroup Initiated AMGN at Neutral (Feb 25, 2016). Previously, Credit Suisse Initiated AMGN at to Outperform. When considering if the stock is under or overvalued, the average price target is $182.50, which is 14.35% above where the stock opened this morning. See more in (NASDAQ:AMGN) Similar Articles: Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces 2016 Second Quarter Dividend Stock Update: Amgen Inc (NASDAQ:AMGN) – Unilife and Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems